Telephone: 972-2-6586774; Fax: 972-2--584972
Embryonic Stem Cells/Induced Pluripotent Stem Cells
Article first published online: 26 AUG 2009
Copyright © 2009 AlphaMed Press
Volume 27, Issue 11, pages 2686–2690, November 2009
How to Cite
Pick, M., Stelzer, Y., Bar-Nur, O., Mayshar, Y., Eden, A. and Benvenisty, N. (2009), Clone- and Gene-Specific Aberrations of Parental Imprinting in Human Induced Pluripotent Stem Cells. STEM CELLS, 27: 2686–2690. doi: 10.1002/stem.205
Author contributions: M.P.: conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing; Y.S.: conception and design, collection and assembly of data, data analysis, interpretation and manuscript writing; O.B.: collection and assembly of data, provision of study material, final approval of manuscript; M.P., Y.S., and O.B. contributed equally to this work; Y.M.: provision of study material, data analysis and interpretation, final approval of manuscript; A.E.: Data analysis and interpretation, manuscript writing, final approval of manuscript. N.B.: conception and design, financial support, data analysis and interpretation, manuscript writing, final approval of manuscript.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS 2009.
- Issue published online: 6 NOV 2009
- Article first published online: 26 AUG 2009
- Accepted manuscript online: 26 AUG 2009 12:00AM EST
- Manuscript Accepted: 12 AUG 2009
- Manuscript Received: 12 MAY 2009
- European Community (ESTOOLS). Grant Number: 018739
- Israel Cancer Research Fund (New York)
- Legacy Heritage Fund
- 1Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet 2008; 17: 1427–1435., , et al.
- 2Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007; 25: 803–816., , et al.
- 3Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum Mol Genet 2007; 16: R243–R251., , .
- 4Epigenetic status of human embryonic stem cells. Nat Genet 2005; 37: 585–587., , .
- 5Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872., , et al.
- 6Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917–1920., , et al.
- 7In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318–324., , et al.
- 8Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 2009; 4: 200-201., , et al.
- 9Epigenetic instability in ES cells and cloned mice. Science 2001; 293: 95–97., , et al.
- 10A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008; 3: 340–345., , et al.
- 11Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res 2007; 1: 105–115., , et al.
- 12Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141–146., , et al.
- 13Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008; 105: 2883–2888., , et al.
- 14Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277–280., , et al.
- 15Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797–801., , et al.
- 16Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008; 112: 1489–1502., , et al.
- 17Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res 1999; 59: 5449–5451., , et al.
- 18Imprinting, expression, and localisation of DLK1 in Wilms tumours. J Clin Pathol 2005; 58: 145–150., , et al.
- 19Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: Analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005; 92: 1574–1580., , et al.